During day
trading
hours,
there
were
many
stocks
that
continued
to
break
up
to
the
upside.These
stocks
are
usually
going
up
or
down
on
with
news.If
you
are
looking
to
day
trade
today,
you
might
want
to
check
out
the
following
stocks. I
usually
throw
these
on
my
watch
list
and
monitor
with
resistance
&
support
levels.
Below
are a
list
of
stocks
that I
am
watching
for
today.You can also check previous stocks to buy reports- Right Here
Stock Trading Signals's Top #PreMarket Gainers
Pre-open movers
US
stock futures fell in early pre-market trading. Alcoa (NYSE:) is expected to
release its quarterly earnings after the closing bell. The NFIB Small Business
Optimism Index for March will be released at 7:30
a.m. ET. Futures for the Dow Jones Industrial Average tumbled 36
points to 16,142.00, while the Standard & Poor's 500 index futures fell
3.90 points to 1,834.20. Futures for the Nasdaq 100 index dropped 5.25 points
to 3,494.00.
A Peek Into Global Markets
European markets were lower today, with the Spanish Ibex
Index falling 1.99%, London's FTSE
100 index dropping 1.03% and STOXX Europe 600 Index falling 0.95%. German DAX
30 index tumbled 1.15% and French CAC 40
Index fell 0.99%. France's
trade deficit declined to EUR3.4 billion in February, versus EUR5.7 billion, in
the year-ago period.
Asian markets ended mostly higher today. Japan's
Nikkei Stock Average fell 1.36%, Hong Kong's Hang Seng
Index gained 0.98% and China's
Shanghai Composite surged 1.92%.
Broker Recommendation
Analysts at Wunderlich downgraded Cisco Systems (NASDAQ: CSCO)
from “buy” to “hold.” The target price for Cisco has been lowered from $25 to
$24.
Cisco's shares fell 0.17% to $47.03 in pre-market trading.
Breaking news
◾ Oncolytics Biotech (NASDAQ: ONCY) today announced
additional data from the Company's randomized, double-blinded clinical study
examining REOLYSIN in combination with carboplatin and paclitaxel in patients
with second-line, platinum-refractory, taxane-naïve head and neck cancers (REO
018).
◾ IMAX (NYSE: IMAX)
today announced the investment in its Greater China business by CMC
Capital Partners (CMC), China's leading
investment fund that is run by Ruigang Li and focused on media and
entertainment, and FountainVest Partners (FountainVest), a leading
China-focused private equity firm.
◾ Stemline Therapeutics (NASDAQ: STML) announced today that
the U.S. Food and Drug Administration (FDA) has accepted the company's
Investigational New Drug (IND) application
for SL-701, which enables the company to advance SL-701 into a Phase 2 trial of
adults with glioblastoma multiforme (GBM) in first recurrence.
◾ Samsung Electronics Co (OTC: SSNLF) forecast a drop in its
operating profit for the three months ended March 31.
For the latest updates on the stock market, visit,
